233 related articles for article (PubMed ID: 17943265)
1. [Developments and perspectives in radioablative techniques].
Jakobs TF; Hoffmann RT; Tatsch K; Trumm C; Reiser MF; Helmberger TK
Radiologe; 2007 Dec; 47(12):1083-8. PubMed ID: 17943265
[TBL] [Abstract][Full Text] [Related]
2. [Update on chemoinfusion and chemoembolization treatments].
Lubienski A; Simon M; Lubienski K; Gellissen J; Hoffmann RT; Jakobs TF; Helmberger T
Radiologe; 2007 Dec; 47(12):1097-106, 1108. PubMed ID: 17992500
[TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study.
Kwon JH; Kim GM; Han K; Won JY; Kim MD; Lee DY; Lee J; Choi W; Kim YS; Kim DY; Han KH
Cardiovasc Intervent Radiol; 2018 Mar; 41(3):459-465. PubMed ID: 29067511
[TBL] [Abstract][Full Text] [Related]
4. Y90 Radioembolization Dosimetry: Concepts for the Interventional Radiologist.
Toskich BB; Liu DM
Tech Vasc Interv Radiol; 2019 Jun; 22(2):100-111. PubMed ID: 31079706
[TBL] [Abstract][Full Text] [Related]
5. Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial.
Seinstra BA; Defreyne L; Lambert B; Lam MG; Verkooijen HM; van Erpecum KJ; van Hoek B; van Erkel AR; Coenraad MJ; Al Younis I; van Vlierberghe H; van den Bosch MA
Trials; 2012 Aug; 13():144. PubMed ID: 22913492
[TBL] [Abstract][Full Text] [Related]
6. Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma.
Salem R; Lewandowski RJ; Kulik L; Wang E; Riaz A; Ryu RK; Sato KT; Gupta R; Nikolaidis P; Miller FH; Yaghmai V; Ibrahim SM; Senthilnathan S; Baker T; Gates VL; Atassi B; Newman S; Memon K; Chen R; Vogelzang RL; Nemcek AA; Resnick SA; Chrisman HB; Carr J; Omary RA; Abecassis M; Benson AB; Mulcahy MF
Gastroenterology; 2011 Feb; 140(2):497-507.e2. PubMed ID: 21044630
[TBL] [Abstract][Full Text] [Related]
7. [Radioembolization with (90)Y-microspheres for liver tumors].
RodrÃguez-Fraile M; Iñarrairaegui M
Rev Esp Med Nucl Imagen Mol; 2015; 34(4):244-57. PubMed ID: 25911062
[No Abstract] [Full Text] [Related]
8. Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinoma.
Abdel-Rahman OM; Elsayed Z
Cochrane Database Syst Rev; 2016 Feb; 2():CD011313. PubMed ID: 26905230
[TBL] [Abstract][Full Text] [Related]
9. Transarterial chemoembolization versus transarterial radioembolization in hepatocellular carcinoma: optimization of selecting treatment modality.
Kim DY; Han KH
Hepatol Int; 2016 Nov; 10(6):883-892. PubMed ID: 27126821
[TBL] [Abstract][Full Text] [Related]
10. Liver metastases from colorectal cancer: radioembolization with systemic therapy.
Nicolay NH; Berry DP; Sharma RA
Nat Rev Clin Oncol; 2009 Dec; 6(12):687-97. PubMed ID: 19884901
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis: adjusted indirect comparison of drug-eluting bead transarterial chemoembolization versus
Ludwig JM; Zhang D; Xing M; Kim HS
Eur Radiol; 2017 May; 27(5):2031-2041. PubMed ID: 27562480
[TBL] [Abstract][Full Text] [Related]
12. [Liver chemoembolization: an update].
Roche A
Bull Cancer; 2009 Nov; 96(11):1111-6. PubMed ID: 19864205
[TBL] [Abstract][Full Text] [Related]
13. Interventional radiology for hepatocellular carcinoma.
Loffroy R
Minerva Gastroenterol Dietol; 2011 Sep; 57(3):299-309. PubMed ID: 21769079
[TBL] [Abstract][Full Text] [Related]
14. Transarterial chemoembolization and yittrium-90 for liver cancer and other lesions.
Minocha J; Salem R; Lewandowski RJ
Clin Liver Dis; 2014 Nov; 18(4):877-90. PubMed ID: 25438288
[TBL] [Abstract][Full Text] [Related]
15. Transcatheter intraarterial therapies: rationale and overview.
Lewandowski RJ; Geschwind JF; Liapi E; Salem R
Radiology; 2011 Jun; 259(3):641-57. PubMed ID: 21602502
[TBL] [Abstract][Full Text] [Related]
16. Standards of practice in transarterial radioembolization.
Mahnken AH; Spreafico C; Maleux G; Helmberger T; Jakobs TF
Cardiovasc Intervent Radiol; 2013 Jun; 36(3):613-22. PubMed ID: 23511991
[No Abstract] [Full Text] [Related]
17. Yttrium-90 microsphere radioembolotherapy of hepatic metastatic neuroendocrine carcinomas after hepatic arterial embolization.
Murthy R; Kamat P; Nunez R; Madoff DC; Gupta S; Salem R; Yao JC
J Vasc Interv Radiol; 2008 Jan; 19(1):145-51. PubMed ID: 18192482
[TBL] [Abstract][Full Text] [Related]
18. Liver chemoembolization of hepatocellular carcinoma using TANDEM
Delicque J; Guiu B; Boulin M; Schwanz H; Piron L; Cassinotto C
Future Oncol; 2018 Nov; 14(26):2761-2772. PubMed ID: 29953255
[TBL] [Abstract][Full Text] [Related]
19. Arterial therapies of non-colorectal cancer metastases to the liver (from chemoembolization to radioembolization).
Hoffmann RT; Paprottka P; Jakobs TF; Trumm CG; Reiser MF
Abdom Imaging; 2011 Dec; 36(6):671-6. PubMed ID: 21584635
[TBL] [Abstract][Full Text] [Related]
20. Fluoroscopic Radiation Exposure in Chemoembolization and Radioembolization: Results from a Prospective Randomized Study.
Gabr A; Kallini JR; Lewandowski RJ; Salem R
J Vasc Interv Radiol; 2017 Sep; 28(9):1272-1273. PubMed ID: 28841927
[No Abstract] [Full Text] [Related]
[Next] [New Search]
